CH386051A - Verfahren zur Herstellung eines Impfstoffes zur gleichzeitigen Immunisierung von Hunden oder Füchsen gegen Staupe und Hepatitis contagiosa canis - Google Patents

Verfahren zur Herstellung eines Impfstoffes zur gleichzeitigen Immunisierung von Hunden oder Füchsen gegen Staupe und Hepatitis contagiosa canis

Info

Publication number: CH386051A
Authority: CH; Switzerland
Prior art keywords: hepatitis; distemper; virus; canis; dogs
Prior art date: 1961-06-21

Application number

CH732762A

Other languages

German (de)

English (en)

Inventor

Kurt Dr Draeger

Othmar Dr Ackermann

Original Assignee

Behringwerke Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1961-06-21

Filing date

1962-06-19

Publication date

1964-12-31

1962-06-19 Application filed by Behringwerke Ag filed Critical Behringwerke Ag

1964-12-31 Publication of CH386051A publication Critical patent/CH386051A/de

Links

241000282472 Canis lupus familiaris Species 0.000 title claims description 29
208000000655 Distemper Diseases 0.000 title claims description 29
208000006454 hepatitis Diseases 0.000 title claims description 29
231100000283 hepatitis Toxicity 0.000 title claims description 29
229960005486 vaccine Drugs 0.000 title claims description 13
238000000034 method Methods 0.000 title claims description 9
230000003053 immunization Effects 0.000 title claims description 7
238000002649 immunization Methods 0.000 title claims description 7
241000282421 Canidae Species 0.000 title claims description 5
238000004519 manufacturing process Methods 0.000 title claims description 5
241000700605 Viruses Species 0.000 claims description 30
241000282465 Canis Species 0.000 claims description 28
210000001519 tissue Anatomy 0.000 claims description 13
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 12
239000000725 suspension Substances 0.000 claims description 7
239000000463 material Substances 0.000 claims description 5
DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 claims description 4
239000000203 mixture Substances 0.000 claims description 4
235000010267 sodium hydrogen sulphite Nutrition 0.000 claims description 4
LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical class OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 claims description 3
150000008043 acidic salts Chemical class 0.000 claims description 3
238000000605 extraction Methods 0.000 claims description 3
210000004185 liver Anatomy 0.000 claims description 3
WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims description 3
238000002156 mixing Methods 0.000 claims description 3
210000000952 spleen Anatomy 0.000 claims description 3
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims description 2
235000015278 beef Nutrition 0.000 claims description 2
239000008103 glucose Substances 0.000 claims description 2
210000002966 serum Anatomy 0.000 description 8
208000015181 infectious disease Diseases 0.000 description 5
238000012360 testing method Methods 0.000 description 5
206010037660 Pyrexia Diseases 0.000 description 4
235000013601 eggs Nutrition 0.000 description 4
208000027744 congestion Diseases 0.000 description 3
208000024891 symptom Diseases 0.000 description 3
238000002255 vaccination Methods 0.000 description 3
241000712083 Canine morbillivirus Species 0.000 description 2
235000014676 Phragmites communis Nutrition 0.000 description 2
230000010530 Virus Neutralization Effects 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
230000000295 complement effect Effects 0.000 description 2
239000012530 fluid Substances 0.000 description 2
238000004108 freeze drying Methods 0.000 description 2
230000003472 neutralizing effect Effects 0.000 description 2
235000015097 nutrients Nutrition 0.000 description 2
241000287828 Gallus gallus Species 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
238000011888 autopsy Methods 0.000 description 1
238000001816 cooling Methods 0.000 description 1
230000000120 cytopathologic effect Effects 0.000 description 1
238000001514 detection method Methods 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
230000000694 effects Effects 0.000 description 1
210000000981 epithelium Anatomy 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
208000005252 hepatitis A Diseases 0.000 description 1
238000002955 isolation Methods 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
210000003292 kidney cell Anatomy 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
210000005084 renal tissue Anatomy 0.000 description 1
239000000126 substance Substances 0.000 description 1
238000012795 verification Methods 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/175—Canine distemper virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Mycology (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pulmonology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

CH732762A 1961-06-21 1962-06-19 Verfahren zur Herstellung eines Impfstoffes zur gleichzeitigen Immunisierung von Hunden oder Füchsen gegen Staupe und Hepatitis contagiosa canis CH386051A (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DEB62972A DE1149495B (de)	1961-06-21	1961-06-21	Verfahren zur Herstellung eines Impfstoffes zur gleichzeitigen Immunisierung von Hunden oder Fuechsen gegen Staupe und Hepatitis contagiosa canis

Publications (1)

Publication Number	Publication Date
CH386051A true CH386051A (de)	1964-12-31

Family

ID=6973794

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CH732762A CH386051A (de)	1961-06-21	1962-06-19	Verfahren zur Herstellung eines Impfstoffes zur gleichzeitigen Immunisierung von Hunden oder Füchsen gegen Staupe und Hepatitis contagiosa canis

Country Status (7)

Country	Link
BE (1)	BE619228A (fr)
BR (1)	BR6240055D0 (fr)
CH (1)	CH386051A (fr)
DE (1)	DE1149495B (fr)
FI (1)	FI40921B (fr)
GB (1)	GB971724A (fr)
LU (1)	LU41770A1 (fr)

1961
- 1961-06-21 DE DEB62972A patent/DE1149495B/de active Pending
1962
- 1962-03-02 FI FI44962A patent/FI40921B/fi active
- 1962-05-11 GB GB1829862A patent/GB971724A/en not_active Expired
- 1962-05-24 LU LU41770D patent/LU41770A1/xx unknown
- 1962-06-15 BR BR14005562A patent/BR6240055D0/pt unknown
- 1962-06-19 CH CH732762A patent/CH386051A/de unknown
- 1962-06-21 BE BE619228A patent/BE619228A/fr unknown

Also Published As

Publication number	Publication date
LU41770A1 (fr)	1962-07-24
BE619228A (fr)	1962-12-21
FI40921B (fr)	1969-03-31
BR6240055D0 (pt)	1973-05-15
GB971724A (en)	1964-10-07
DE1149495B (de)	1963-05-30

Publication	Publication Date	Title
NO144005B (no)	1981-02-23	Skistoevel.
US4224412A (en)	1980-09-23	Living virus culture vaccine against canine distemper and method of preparing same
DE2708668A1 (de)	1977-09-08	Nd-impfstoff und verfahren zu seiner herstellung
DE2713371C2 (fr)	1989-01-05
DE2817891A1 (de)	1978-11-09	Nd-impfstoff und verfahren zu seiner herstellung
DE2463143C2 (de)	1985-04-11	Polyvalente Rindervirus-Lebendimpfstoffe
DE2817299A1 (de)	1978-10-26	Verfahren zur herstellung eines attenuierten infektioese-gastroenteritis (tge)-virusstammes zur anwendung in lebendvakzinen
DE2362067C2 (de)	1985-11-28	Temperaturempfindliche, nicht-pathogene, infektiöse Rinder-Rhinotracheitis-Virusstämme, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Lebendimpfstoffen
DE2120929A1 (de)	1971-11-18	Impfstoff für Geflügel gegen die Mareksche Hühnerlähme und Verfahren zu seiner Herstellung
DE2538994A1 (de)	1976-06-16	Bakterieller impfstoff und verfahren zu seiner herstellung
AT233167B (de)	1964-04-25	Verfahren zur Herstellung eines Impfstoffes zur gleichzeitigen Immunisierung von Hunden oder Füchsen gegen Staupe und Hepatitis contagiosa canis
DE1149495B (de)	1963-05-30	Verfahren zur Herstellung eines Impfstoffes zur gleichzeitigen Immunisierung von Hunden oder Fuechsen gegen Staupe und Hepatitis contagiosa canis
DE1792356C2 (de)	1983-03-03	Staupe-Kombinationsvaccinen und Verfahren zu ihrer Herstellung
Macpherson et al.	1978	Some observations on the value of the infectious bronchitis haemagglutination inhibition test in the field
CH380302A (de)	1964-07-31	Verfahren zur Herstellung einer kombinierten Vaccine für Hunde
DE1235505B (de)	1967-03-02	Verfahren zur Herstellung einer Vaccine gegen Staupe
CH397957A (de)	1965-08-31	Verfahren zur Herstellung eines Impfstoffes zur gleichzeitigen Immunisierung von Hunden oder Füchsen gegen Staupe, Hepatitis contagiosa canis und Leptospirose (Stuttgarter Hundeseuche und Weil'sche Krankheit)
AT227876B (fr)	1963-06-10
DE2225548A1 (de)	1973-12-06	Intravenoes vertraegliche staupe- und hepatitisvaccine
DE2057544A1 (de)	1971-06-09	Verfahren zur Herstellung einer Virusvakzine gegen das Kaelberdiarrhoevirus
AT234902B (de)	1964-07-27	Verfahren zur Herstellung einer Vaccine gegen Staupe
DE1021128B (de)	1957-12-19	Verfahren zur Herstellung eines Impfstoffes gegen die Rhinotracheitis der Rinder
DE2126957A1 (de)	1972-12-07	Impfstoff gegen Gänsehepatitis
DE2809343C2 (de)	1982-06-03	Impfstoff gegen Eierlege-Krankheit
DE1253412B (de)	1967-11-02	Verfahren zur Gewinnung eines Impfstoffes gegen infektioese Schweinegastroenteritis